跳至主要内容
临床试验/NCT05768763
NCT05768763已完成不适用

SEARCH Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa Phase B

University of California, San Francisco4 个研究点 分布在 2 个国家目标入组 81,952 人开始时间: 2023年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
81,952
试验地点
4
主要终点
HIV incidence

研究概览

简要总结

This study will evaluate the effects of optimized dynamic prevention and treatment packages delivered in a precision community health model on HIV incidence, as well as other health outcomes, in a community randomized trial design.

详细描述

In the "evaluation" Phase B, the SEARCH SAPPHIRE study will evaluate the effects of Dynamic Prevention and Dynamic Treatment intervention packages based on data from Phase A (NCT04810650) and new advances from outside the study delivered in a precision community health model, on HIV incidence and other health outcomes, in a pair-matched community randomized design.

The Phase B precision community health intervention will consist of a three part intervention: 1) Community-enhanced reach activities 2) Person-centered care delivery; and, 3) Data-enhancement to improve precision of interventions.

The study hypothesis for the Phase B population level study is: A Precision Community Health Model leveraging existing facility-based outreach and community health workers, enabled by dynamic choice prevention/treatment multi-disease approaches and interactive data systems -will reduce HIV infections, deaths and improve health.

Structured stakeholder consultations are formally incorporated in the study design and leverage regular and ongoing collaborations the study team has with the HIV, non-communicable disease and general health leads in Kenya and Uganda Ministries of Health and PEPFAR implementing partners at the national and the regional level.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 15 years
  • Living in SEARCH study communities
  • Provided informed consent

排除标准

  • <15 years of age
  • Living outside SEARCH study communities
  • Unable to provide consent or parental co-consent as per country guidelines

研究组 & 干预措施

Precision Community Health

Experimental

The Phase B precision community health intervention will consist of a three part intervention: 1) Community-enhanced reach activities 2) Person-centered care delivery; and, 3) Data system enhancement to improve reach and person-centered delivery

干预措施: Community-enhanced reach activities (Behavioral)

Precision Community Health

Experimental

The Phase B precision community health intervention will consist of a three part intervention: 1) Community-enhanced reach activities 2) Person-centered care delivery; and, 3) Data system enhancement to improve reach and person-centered delivery

干预措施: Person-centered care delivery (Behavioral)

Precision Community Health

Experimental

The Phase B precision community health intervention will consist of a three part intervention: 1) Community-enhanced reach activities 2) Person-centered care delivery; and, 3) Data system enhancement to improve reach and person-centered delivery

干预措施: Data system enhancement to improve reach and person-centered delivery (Other)

Control

Active Comparator

Standard of Care

干预措施: Standard of Care (Behavioral)

结局指标

主要结局

HIV incidence

时间窗: 24 months

HIV incidence per 100 person-year

次要结局

  • Population-Level Viremia(24 months)
  • Prevention Coverage(assessed between 18-24 month follow up)
  • Population Level Viral Suppression among PWH(assessed between 18-24 month follow up)
  • Mortality risk(assessed between 18-24 month follow up)
  • Hypertension Control(assessed between 18-24 month follow up)
  • Severe Hypertension(assessed between 18-24 month follow up)
  • Persons presenting with late HIV disease(assessed between 18-24 month follow up)
  • Late Pediatric HIV Diagnosis(assessed between 18-24 month follow up)
  • Heavy Alcohol Use(assessed between 18-24 month follow up)
  • HPV Immunization Coverage(assessed between 18-24 month follow up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验